Close this search box.

A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.

The aim of this trial is to investigate whether pre-operative treatment with chemotherapy plus radiation therapy has a better outcome than chemotherapy alone in patients undergoing surgery for resectable gastric cancer.

Primary Sponsor

Australasian Gastro-Intestinal Trials Group (AGITG)

Collaborating Groups

TROG Cancer Research; Canadian Cancer Trial Group (CCTG); European Organisation for Research & Treatment of Cancer (EORTC); National Health and Medical Research Council Clinical Trials Centre (NHMRC CTC)

Accrual Target


Expected Date of Accrual

31 December 2020

Trial Chairperson

Professor Trevor Leong, Peter MacCallum Cancer Centre, VIC

Trial Contact

Related Post

October 18, 2022

NINJA Radiation Therapy Trial participant tells his journey to treatment

The journey to becoming the 200th participant for the

September 6, 2022

The gift that kept on giving

The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing